Grifols (GIFLF) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025)

Grifols (GIFLF) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 5.56%
Dec 31, 2024 8.36%
Dec 31, 2023 -11.38%
Dec 31, 2022 10.21%
Dec 31, 2021 8.32%
Dec 31, 2020 8.98%
Sep 30, 2020 37.53%
Mar 31, 2020 52.92%
Dec 31, 2019 10.75%
Dec 31, 2018 14.27%
Sep 30, 2018 78.64%
Jun 30, 2018 95.15%
Mar 31, 2018 125.60%
Dec 31, 2017 14.55%
Jun 30, 2017 9.66%
Dec 31, 2016 13.32%
Sep 30, 2016 72.41%
Jun 30, 2016 3.70%
Dec 31, 2015 76.83%
Sep 30, 2015 51.13%